Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Talking about front-of-package labeling

This article was originally published in The Tan Sheet

Executive Summary

FDA seeks information comparing the efficacy of possible front-of-package nutrition labeling and how the labeling affects consumers' choices, according to an April 29 Federal Register 1notice. FDA also asks for marketing and advertising data to help develop better point-of-purchase nutrition information, and comments on how this information may affect firms' decisions to reformulate food products. FDA will accept comments through July 28. The agency in October said it would examine FOP programs and shelf labels to ensure they are not false or misleading after Rep. Rosa DeLauro, D-Conn., asked it to investigate whether the Smart Choices voluntary FOP labeling misrepresented food choices (2"The Tan Sheet" Oct. 26, 2009, In Brief)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104078

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel